What sector does Advanced Enzyme Tech Ltd belong to?

Advanced Enzyme Tech Ltd operates in the Healthcare sector, specifically the Biotechnology industry, and is listed on the NSE.

What is the current share price of ADVENZYMES?

As of the latest available quote, ADVENZYMES traded at ₹293.40. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of ADVENZYMES?

Advanced Enzyme Tech Ltd has a price-to-earnings (P/E) ratio of about 19.84. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of ADVENZYMES?

The market capitalisation of Advanced Enzyme Tech Ltd is approximately ₹3,285 Cr.

Is Advanced Enzyme Tech Ltd profitable?

For its latest reported financial year, Advanced Enzyme Tech Ltd recorded a net profit margin of about 23.32%.

Does ADVENZYMES pay a dividend?

Advanced Enzyme Tech Ltd currently has a dividend yield of about 0.45%.

What is the return on equity (ROE) of ADVENZYMES?

Advanced Enzyme Tech Ltd has a return on equity (ROE) of about 10.20%. ROE measures how much profit a company generates relative to shareholders' equity.

What is the 52-week high and low of ADVENZYMES?

Over the past 52 weeks, ADVENZYMES has traded between a low of ₹251.95 and a high of ₹419.00.

Advanced Enzyme Tech Ltd

ADVENZYMES NSE Healthcare Biotechnology

Microcap 250

₹293.40

-3.28%

Delayed · cached 15 min

Fair value analysis

ADVENZYMES

Advanced Enzyme Tech Ltd

₹303.35

Close used for this calculation

₹414.90Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

65/100

Profitability23/25

Returns10/25

Balance Sheet21/25

Efficiency11/25

Growth20/25

Strong

Quality radar

Consensus fair value

₹414.90

Below FV

▲ +36.8% against the close used

Model range ₹148.15 – ₹829.60

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₹148.15Fair value₹414.90Bull₹829.60

FairClose

52-week traded range

52W low ₹255.3052W high ₹392.10

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading below the consensus fair value

Advanced Enzyme Tech Ltd closed at ₹303.35, 26.9% below the consensus fair value of ₹414.90 drawn from 10 valuation models.

Financial DNA score 65/100 — Strong. P/E of 20.8x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

₹192.46

-36.6%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=9%, r=10%, tg=3%, n=10yr

Graham Number

₹218.73

-27.9%

√(22.5 × EPS × BVPS)

EPS=15.07, BVPS=141.09 · outside Graham range (P/E 20.8, P/B 2.2) — asset-light, treat as a rough floor

Graham Formula

₹589.13

+94.2%

EPS × (8.5 + 2g) × 6.5 ÷ FD_Rate

g=16.8%, FD=7%

P/E Fair Value

₹829.60

+173.5%

EPS × 55.05x (sector P/E)

EPS=15.07, Sector P/E=55.05x

Peter Lynch (PEG)

₹253.18

-16.5%

EPS × Growth% (PEG = 1 is fair)

EPS=15.07, g=16.8%

EV/EBITDA

₹445.84

+47.0%

(EBITDA × 18x − Net Debt) ÷ Shares

EBITDA=2.7B

Dividend Discount (DDM)

₹298.13

-1.7%

D1 ÷ (r − g) where D1 = D0×(1+g)

D0=5.52, r=10%, g=8%

Book Value (P/B)

₹148.15

-51.2%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=141.09, ROE=10.2%, g=6%, r=10%

Reverse DCF

₹303.35

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: 7.2% | Historical: 16.8%

Margin of Safety

₹343.11

+13.1%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=457.48, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer